🔎 Trials Near Me

መነሻ › Multiple Myeloma › አላባማ › Birmingham

በBirmingham፣ AL ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 18 ጥናቶች በBirmingham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Alabama At Birmingham Hospital, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT04973605

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Alabama Oncology, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07518186

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04634552

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Alabama at Birmingham Hospital, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT02693535

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06297226

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06988488

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05850234

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁላይ 2026 · NCT06121843

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham, Birmingham
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06974786

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT06153251

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama at Birmingham, Birmingham
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT07333261

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ዲሴም 2025 · NCT04991103

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

ተሳታዮችን በመፈለግ ላይ
  • Kirklin Clinic of UAB Hospital, Birmingham
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ዲሴም 2025 · NCT05642884

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Kirklin Clinic of UAB Hospital, Birmingham
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ዲሴም 2025 · NCT05556928

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UAB Comprehensive Cancer Center, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሴፕቴ 2025 · NCT05372354

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በBirmingham ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።